As part of the partnership, BioCardia has licensed global exclusive rights to CART-Tech intellectual property for the fields of biotherapeutic intervention. CART-Tech has licensed global exclusive ...

LIXTE will continue to closely monitor developments in the digital asset space and retains the flexibility to adjust its holdings. The Company intends to hold all cryptocurrency assets with a fully ...

Net loss was $23.1 million for the second quarter of 2025, resulting in a basic and diluted net loss per share of $0.90. Net loss was $17.5 million for the second quarter of 2024, resulting in basic ...

EMERYVILLE, Calif., Aug. 13, 2025 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (NASDAQ: XOMA), the biotech royalty aggregator, reported its 2025 second quarter and year to date financial results and ...

Event: H.C. Wainwright 27 th Annual Global Investment Conference Location: New York, NY Date and Presentation Time: 12:30 PM Eastern Time on September 10, 2025 Event Format: Presentations and 1-on-1 ...

In connection with the offering, Nasus Pharma’s Ordinary Shares have been approved for listing on the NYSE American LLC. The Ordinary Shares are expected to begin trading on the NYSE American LLC on ...

As of June 30, 2025, Aura had cash and cash equivalents and marketable securities totaling $177.3 million. The Company believes its current cash and cash equivalents and marketable securities are ...

Denifanstat was generally well-tolerated and, following 12 weeks of once-daily oral administration at 50 mg, the incidence rates of treatment-emergent adverse events (TEAE) were comparable between ...

“This platform launch marks a pivotal moment for inpatient mental health care,” said Todd Haedrich, CEO of LIO. “LIO represents a fundamental evolution of our capabilities, addressing the most ...

TAUNTON, U.K., Aug. 13, 2025 (GLOBE NEWSWIRE) -- Corza Medical, a leading global manufacturer of surgical technologies and medical device components announced today the launch of its Biomedical ...

The Company's application to expand Flamingo-01 into Romania has been formally approved by European regulators, thus adding Romanian sites to the approximately 150 approved sites in Spain, France, ...

In August, ImmuneOnco announced that an abstract has been accepted for poster presentation at IASLC’s 2025 World Conference on Lung Cancer (September 6 th -9 th, 2025), which will provide updated ...